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Abstract
Although enteropathogenic Escherichia coli (EPEC) are well-recognized diarrheal agents, their ability to translocate and cause 
extraintestinal alterations is not known. We investigated whether a typical EPEC (tEPEC) and an atypical EPEC (aEPEC) 
strain translocate and cause microcirculation injury under conditions of intestinal bacterial overgrowth. Bacterial translocation 
(BT) was induced in female Wistar-EPM rats (200-250 g) by oroduodenal catheterization and inoculation of 10 mL 1010 colony 
forming unit (CFU)/mL, with the bacteria being confined between the duodenum and ileum with ligatures. After 2 h, mesenteric 
lymph nodes (MLN), liver and spleen were cultured for translocated bacteria and BT-related microcirculation changes were 
monitored in mesenteric and abdominal organs by intravital microscopy and laser Doppler flow, respectively. tEPEC (N = 11) 
and aEPEC (N = 11) were recovered from MLN (100%), spleen (36.4 and 45.5%), and liver (45.5 and 72.7%) of the animals, 
respectively. Recovery of the positive control E. coli R-6 (N = 6) was 100% for all compartments. Bacteria were not recovered 
from extraintestinal sites of controls inoculated with non-pathogenic E. coli strains HB101 (N = 6) and HS (N = 10), or saline. 
Mesenteric microcirculation injuries were detected with both EPEC strains, but only aEPEC was similar to E. coli R-6 with re-
gard to systemic tissue hypoperfusion. In conclusion, overgrowth of certain aEPEC strains may lead to BT and impairment of 
the microcirculation in systemic organs.
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Bacterial translocation (BT) is defined as the migration 
of indigenous bacteria as well as their products from the 
intestinal lumen to the mesenteric lymph nodes and to 
other extraintestinal sites (1). Gut bacterial overgrowth, 
intestinal barrier disruption, and immune deficiency condi-
tions have been proposed as the three major BT-inducing 
factors (2).
According to a growing consensus, under physiologi-
cal conditions, BT occurs regularly for intestinal microbe 
presentation and this event has been referred to as the 
gut immune enhancing mechanism (3). The experimental 
and clinical demonstrations of this phenomenon are based 
on mesenteric lymph nodes (MLN) showing positive cul-
ture. However, in critically ill patients, such as patients in 
shock, with sepsis and burns, BT seems to promote the 
exacerbation of inflammatory responses, attributed to the 
crosstalk between the gut and systemic immunity through 
the lymphatic route communication by carrying gut-derived 
pro-inflammatory products to the bloodstream (4,5). 
We have previously identified an indigenous naturally 
tetracycline-resistant Escherichia coli strain (E. coli R-6, 
serotype ONT:H2) in the mesenteric lymph nodes and 
Peyer’s patches of a rat, after 10 days of antibiotic therapy 
(6). At high concentrations (1010 colony forming unit (CFU)/
mL), E. coli R-6 confined in the small bowel of rats caused 
consistent and substantial translocation to MLN, liver and 
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spleen with marked injury to the mesenteric microcirculation 
(7). Such events lead to tissue hypoperfusion of the gut 
and abdominal organs and are attributed to the lymphatic 
route of BT by triggering gut-associated lymphoid tissue 
(GALT) activation and pro-inflammatory cytokine release 
into the systemic compartment, resulting in the amplifica-
tion of the host inflammatory state (8). In addition, when 
the BT process was associated with non-lethal sepsis, an 
increased mortality rate was observed (9) 
Although commensal E. coli strains are usually non-
virulent, when one or more BT-predisposing factors are 
present in the host, they can translocate and consequently 
generate or aggravate an infectious illness (4,10). 
Enteropathogenic E. coli (EPEC) is one of the six categories 
of diarrheagenic E. coli (11), divided into typical and atypical 
EPEC (tEPEC and aEPEC, respectively). Although tEPEC are 
leading agents of infantile diarrhea in developing countries, 
they are rarely detected in industrialized countries, where 
aEPEC seem to be more important diarrheal agents (12-14). 
By definition, the main difference between tEPEC and aEPEC 
is the presence of the so-called EPEC adherence factor (EAF) 
plasmid, which is found only in tEPEC strains (12,15). 
The main mechanism of EPEC pathogenesis is at-
tributed to an attaching and effacing (AE) lesion, which 
is encoded by a chromosomal pathogenicity island called 
“locus of enterocyte effacement” (LEE) (11,14). Among 
various other proteins, LEE encodes the outer membrane 
adhesive protein intimin and its translocated receptor Tir 
(translocated intimin receptor) (11,14). Besides loss of 
absorptive microvilli due to the AE lesion (16), it has been 
shown that the coordinated activities of various proteins 
secreted by EPEC trigger several other changes in the in-
testine (16,17), leading to the establishment of diarrhea.
In the present study, we analyzed the potential of both 
tEPEC and aEPEC to translocate from the intestine and 
spread into the systemic bloodstream, thus causing sys-
temic alterations under a situation of intestinal bacterial 
overgrowth.
Material and Methods
Microbiological procedures
Bacterial strains. aEPEC strain 1711-4 (serotype 
O51:H40) isolated from a child with diarrhea in the city of São 
Paulo, Brazil (1989) and tEPEC prototype strain E2348/69 
(serotype O127:H6) also isolated from a child with diarrhea 
were used. Laboratory strain E. coli HB101 and E. coli strain 
HS (serotype O9:H4), previously isolated from a healthy 
human and which colonize the human gastrointestinal tract 
without producing any apparent clinical symptoms (18), were 
used as non-pathogenic controls. The rat strain E. coli R-6 
(serotype ONT:H2), with the ability to translocate (6), was 
used as a positive BT control. This strain is devoid of the 
main virulence genes of the diarrheagenic E. coli categories, 
including the EPEC eae gene (Vieira MM, Liberatore AMA, 
Koh IHJ, Gomes TAT, unpublished data).
Bacterial growth. Strains were cultured in tryptic soy 
broth or Luria-Bertani broth (Difco, USA). MacConkey agar 
(Difco) and tryptic soy agar (Difco) were used as solid media. 
Incubations were carried out for 18 to 20 h at 37°C. 
Polymerase chain reaction (PCR) analysis. Prior to 
the BT assays, feces were collected from all animals and 
cultivated on MacConkey agar plates. After overnight 
incubation at 37°C, a portion of each of the resulting 
enriched bacterial confluent growth was collected with a 
loop, suspended in saline, and boiled. This suspension 
was used in PCR to assess the presence of the EPEC 
eae gene (encoding intimin) as previously reported (19). 
Amplification reactions were performed with 0.2 mM dNTP, 
1.5 mmol MgCl2, 2.5 U Taq DNA polymerase, and 100 pmol 
of each primer. Amplified products were analyzed on 2% 
agarose gels and visualized by ethidium bromide staining. 
Only animals lacking eae-positive bacteria were used for 
the BT experiments. This procedure was used in order to 
avoid the use of animals colonized by AE-producing E. 
coli strains, as well as the AE-producing mouse pathogen 
Citrobacter rodentium (20). 
Bacterial recovery. Samples of blood, MLN, liver, and 
spleen were collected 2 h post-BT induction, weighed, minced 
(solid tissue), and suspended in a known volume of saline, 
and a 100-µL aliquot was cultured on MacConkey agar plates. 
To confirm the identity of the aEPEC and tEPEC strains 
isolated from distinct organs, PCR analysis of the eae gene 
and serogroup identification were performed. Recovery of the 
HS strain was confirmed by the inability to ferment lactose 
(characteristic of this strain) and serogrouping. 
To confirm the recovery of E. coli R-6, organ suspensions 
were inoculated into tetracycline-containing MacConkey 
agar (20 µg/mL), and the resulting colonies were confirmed 
as E. coli by biochemical assays. Bacterial recovery from 
organs (CFU/g tissue) is reported as the mean log10 value. 
The median value of bacterial recovery from each compart-
ment per gram was referred to as the BT index.
Animals and groups 
Adult female Wistar-EPM rats, weighing 200-250 g, 
received rat chow and water ad libitum. Prior to the experi-
ments, rats were fasted for one day and allowed free access 
to water. Animals were divided into 5 groups: aEPEC (N 
= 11), tEPEC (N = 11), HS (N = 10), HB101 (N = 6), R-6 
(N = 6), and sham (N = 6), where saline was used instead 
of bacteria. For the microcirculation study, four additional 
animals per group were used. 
The study was approved by the Research Ethics Com-
mittee of Universidade Federal de São Paulo.
Bacterial translocation assay
Animals were kept under anesthesia (intramuscular in-
jection of 0.1 mL/100 g body weight ketamine and xylazine, 
4:1) during the entire procedure. An additional half-dose of 
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anesthetic was given when needed. BT was induced by a 
midline incision, oroduodenal cannulation, inoculation of 10 
mL 1010 CFU/mL through the catheter, and confinement 
of the bacteria in a segment between the duodenum and 
ileum using ligatures, for a period of 2 h (6). The inoculation 
of bacteria caused a transient dilatation of the small bowel, 
which disappeared within a short period of time. 
Intravital microcirculation monitoring 
After 2 h of the BT process, animals (N = 4) were re-lap-
arotomized, and the mesenteric microcirculation of the small 
bowel was examined with an intravital video microscope 
(Zeiss Axioskop-2 plus, Germany) to check for leukocyte 
adhesion, hemorrhage and vascular obstruction.
Tissue perfusion 
Tissue perfusion was measured in the 
wall of the small intestine (jejunum and 
ileum), in the liver and in the kidneys us-
ing a laser-Doppler flow meter (BLE-21). 
Measurements were made before (baseline) 
and 2 h after bacterial confinement (final). 
The tissue perfusion unit (TPU) of each 
compartment is reported as the media of TP 
index (% delta) using the following formula: 
% delta = (final TPU - baseline TPU) x 100 / 
baseline TPU.
Statistical analysis 
Analysis of variance (ANOVA), Cochran’s 
G-test and the Fisher exact test were used 
and a P value ≤0.05 was considered to be 
significant.
Results
tEPEC and aEPEC can translocate 
through the intestinal mucosa under 
overgrowth conditions
Like the positive control strain R-6, the 
tEPEC and aEPEC strains were recovered 
from the MLN of all 11 animals (100%), 
whereas the HS strain was recovered from 
8 of 10 animals (80%). Conversely, in the 
systemic organs, the percentage of tEPEC 
translocation was lower than that of aEPEC 
(P > 0.05), occurring in the spleen (36.4 
and 45.4%) and liver (45.5 and 72.7%), 
respectively. Percentages of both tEPEC 
and aEPEC translocation to the spleen and 
liver were significantly lower compared to the 
positive control strain R-6 (P < 0.05). Bacteria 
were not found to be in the extraintestinal 
organs of any of the animals tested with the 
non-pathogenic strains E. coli HB101 and 
HS, or the sham group (Figure 1).
When bacterial recovery was examined quantitatively, 
tEPEC, aEPEC, and E. coli HS showed substantial transloca-
tion to MLN compared to HB101 and sham groups. Conversely, 
tEPEC translocation to MLN was significantly lower compared 
to E. coli R-6 (P < 0.05), whereas translocation of aEPEC was 
as high as with the E. coli R-6 strain. Translocation of both 
aEPEC and R-6 was significantly higher compared to the HS 
strain. However, in systemic organs (liver and spleen) BT was 
significantly reduced in both EPEC groups compared to the R-6 
strain (P < 0.05). In addition, although without any statistical 
differences, aEPEC translocation was always higher than that 
of tEPEC in MLN and liver (Figure 2). These data show that 
only the EPEC and R-6 strains had the ability to translocate by 
both the lymphatic and hematological routes. Blood cultures 
Figure 1. Percentage of animals positive for bacterial translocation (BT) to mes-
enteric lymph nodes (MLN), spleen and liver in a 2-h BT assay. tEPEC = typical 
enteropathogenic Escherichia coli; aEPEC = atypical EPEC; R-6 = positive con-
trol E. coli; HS and HB101 = non-pathogenic E. coli strains. P < 0.05, E. coli R-6 
(*) compared with tEPEC (+) and aEPEC (+) in the spleen and liver (Cochran’s 
G-test and Fisher exact test).
Figure 2. Bacterial recovery in all groups. Data are reported as median log10. 
Statistically significant differences (P < 0.05) for mesenteric lymph nodes (MLN) 
were observed between E. coli R-6 (*) and tEPEC or HS (#), and between aEPEC 
and HS (+). For liver and spleen, significant differences were detected between 
R-6 (*) and tEPEC or aEPEC (#) (ANOVA and Fisher exact test). BT = bacterial 
translocation. See Figure 1 for explanation of abbreviations.
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were negative in all groups. 
When only animals with BT to organs were considered, 
tEPEC and aEPEC recovery was 3.6 and 2.7 log10 for liver 
and 3.4 and 3.12 log10 for spleen, respectively. These 
findings were similar to those for E. coli R-6 (3.4 log10 for 
liver and 3.6 log10 for spleen), suggesting that the differ-
ences between the EPEC groups were mostly related to 
the frequency (%) of the BT event. 
aEPEC and tEPEC have an apparently similar 
potential to induce host mesenteric microcirculation 
injuries compared to E. coli R-6
In the positive control group (R-6), after 2 h of the BT event, 
microcirculation injuries were intense and consisted of multifocal 
capillary hemorrhage, obstruction of low-flow venules, slower 
flow in high-flow venules, and increased leukocyte rolling with 
adhesions mainly on venule endothelial cells (Figure 3B).
BT-related microcirculation injuries of both EPEC strains 
were quite similar to those of E. coli R-6 (Figure 3C and D). 
In all groups, the mesenteric arterioles and high-flow venules 
remained patent with normal blood flow, showing that an acute 
BT induction was unable to damage high-flow blood vessels. 
Microcirculation injuries were not seen in any negative control 
group. 
aEPEC translocation impairs tissue perfusion in a 
systemic manner
Based on the findings of BT-related mesenteric mi-
Figure 3. Mesenteric microcirculation injuries following 2 h of bacterial translocation (BT) as evaluated by intravital 
videomicroscopy. A, Negative control groups: appearance of normal microcirculation with few leukocyte adhesions 
(LA) and preserved blood flow in arterioles (A), capillaries (C), and venules (V). B, E. coli R-6 strain: intense leuko-
cyte adhesion to venules, obstruction (O) in venules and capillaries, multiple focal hemorrhages (MH) in capillaries. 
C, tEPEC strain: increased leukocyte adhesion (LA) to venule endothelial cells and focal hemorrhage (H) in capillar-
ies. D, aEPEC strain: multiple focal hemorrhages in capillaries and obstructions in low-flow venules and capillaries, 
similar to findings for the Escherichia coli R-6 strain. See Figure 1 for explanation of groups.
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crocirculation injury, we examined if this injury could impair 
the tissue perfusion of the gut and of other distant systemic 
organs (Figure 4).
aEPEC caused similar tissue hypoperfusion in the jejunum, 
ileum, liver, and kidneys compared to E. coli R-6, although 
less severely. In contrast, tEPEC caused hypoperfusion only 
in the kidneys and had significantly lower effects than E. coli 
R-6 in the jejunum, ileum and liver. In addition, tEPEC-related 
hypoperfusion was more similar to that caused by the HB101 
and HS strains, while aEPEC hypoperfusion was more similar 
to that caused by E. coli R-6. These data suggest a greater 
systemic inflammatory effect due to aEPEC BT, based on the 
broader tissue hypoperfusion seen with the aEPEC strain 
compared to the tEPEC strain. Nevertheless, a statistically 
significant difference between the effects of aEPEC and tEPEC 
was only seen in the jejunum. 
In the sham group, the injection and confinement of saline 
in the gut increased final TPU in all compartments compared to 
baseline TPU, resulting in a positive TP index. This finding was 
expected on the basis of the assumption that the inoculated 
saline would be absorbed with a resulting increase in blood 
volume, with the ensuing higher tissue perfusion. Similarly, 
the negative BT control groups (E. coli HB101 and HS) also 
showed a positive TP index in the gut and liver, in addition 
to a nonsignificant decrease in the kidneys compared to the 
sham group.
Discussion
In the present study, we observed that both the tEPEC and 
aEPEC strains have the capacity to translocate under condi-
tions of a small bowel overgrowth, not only to MLN but also to 
systemic organs. Besides its BT potential, the aEPEC strain was 
even capable of causing mesenteric microcirculation injuries 
in addition to liver, small gut and kidney hypoperfusion. These 
findings were unexpected because of the consensus that EPEC 
is an infectious agent restricted to the intestinal mucosa. 
Remarkably, the BT capacity of aEPEC was as high as that 
of the positive control strain E. coli R-6, whose translocation 
ability has been consistently demonstrated in an in vivo rat BT 
model (6-8,21). Furthermore, we have also shown previously 
that systemic tissue hypoperfusion by a BT process is mainly 
dependent on GALT activation by the lymphatic route of trans-
location while the hematological route of BT is more related to 
bacterial passage from the gut lumen into the bloodstream and 
further to the systemic organs (22). Furthermore, a recent kinetic 
study of the BT process showed that BT caused a significant 
and long-lasting increased release of inflammatory cytokines 
and lymphocytes into the gut mesenteric efferent lymph (data 
not shown). These findings show that the BT process is of 
significant relevance in the genesis of inflammation, but clinical 
confirmation is still lacking. 
Since splanchnic hypoperfusion leading to gut tissue hy-
poxia and cell damage is one of the key factors related to GALT 
activation (23,24), the aEPEC BT-associated hypoperfusion 
of splanchnic organs reinforces the strain’s pathological 
potential besides its well-known diarrheagenic capacity. 
If we consider only the animals with positive BT to MLN, 
liver and spleen, the BT index was similar for tEPEC, aEPEC 
and E. coli R-6. Thus, the lesser systemic hypoperfusion ef-
Figure 4. Tissue perfusion index of jejunum, ileum, liver, and kidneys following bacterial translocation in 
all groups. Data are reported as median delta % with standard deviation. Statistical findings: In jejunum: 
tEPEC vs aEPEC (P = 0.048) or Escherichia coli R-6 (P = 0.008); aEPEC vs HS (P = 0.002); R-6 vs 
HS (0.0001). In ileum: tEPEC vs R-6 (P = 0.001); aEPEC vs HS (P = 0.006); HS vs R-6 (P = 0.0001). 
In liver: R-6 vs tEPEC or HS (P = 0.003). In right and left kidneys: R-6 vs HS (P = 0.003). HS did not 
differ from the sham and HB101 groups in any organ (ANOVA and Fisher exact test). See Figure 1 for 
explanation of groups.
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fect of the tEPEC strain compared to E. coli R-6 and aEPEC 
suggests its lower systemic inflammatory potential, which 
could be attributed to a lower virulence potential. Studies 
are in progress to determine the EPEC virulence factors 
involved in the BT process and their systemic effects.
In the negative control groups, only E. coli HS was able 
to translocate to MLN, suggesting that the epithelial cell ad-
hesion capacity of the HS strain enabled its translocation to 
MLN in the gut overgrowth state. However, the low amount 
of HS recovery from MLN, the absence of recovery from 
systemic organs, the preserved systemic organ perfusion, 
and mesenteric microcirculation pattern denote its limited 
capacity to activate the host inflammatory response. 
We have recently demonstrated that the EPEC strains 
used in this study are able to cause AE lesions in the in 
vivo rabbit ileal loop model (25). Nonetheless, their ability 
to cause AE lesions in the rat intestine and the mecha-
nisms they use to overcome the mucosal epithelial barrier 
remain to be evaluated. It has already been shown that 
the EPEC-type three secretion system (T3SS) is required 
to induce loss of intestinal barrier function and to support 
translocation across M cells (26). We are currently testing 
an isogenic T3SS mutant of the aEPEC strain used in this 
study to determine whether effector proteins injected by 
this system could play a role in our model of BT. 
Since the microcirculation changes were seen within a 
short BT event, in the case of long-lasting gut overgrowth 
conditions an enduring EPEC BT event could cause greater 
pathological damage. 
Although experimental results are far from clinical 
events, the present findings suggest that diarrheagenic 
EPEC strains have the further potential to promote ex-
traintestinal effects. 
Our findings demonstrate for the first time the capability 
of an aEPEC strain and a tEPEC strain to translocate and 
impair the systemic microcirculation in an experimental 
study. However, other EPEC strains have to be investigated 
to find out if these phenomena are also associated with 
other EPEC strains. 
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